-
US Making COVID Antiviral Drug More Available at Test Sites
The White House has announced more steps to make the antiviral treatment Paxlovid more accessible across the U.S. as it projects COVID-19 infections will continue to spread over the summer travel season. The nation’s first federally backed test-to-treat site is opening Thursday in Rhode Island. The site will provide patients with immediate access to the drug once they test positive....
-
Can COVID Symptoms Rebound? What Experts Say on Puzzling Paxlovid Cases
The COVID-19 pandemic poses another puzzling question that is concerning several patients who have taken Pfizer’s COVID antiviral drug, Paxlovid, and are experiencing rebounding symptoms after initially feeling better. Matthew Boyd, 32, lives on the Lower East Side of Manhattan and tested positive for coronavirus on May 6 with a sore throat, sinus congestion and a mucus-filled cough. The next…
-
Paxlovid ‘Rebound': What Experts Say about COVID Symptoms
The COVID-19 pandemic poses another puzzling question that is concerning several patients who have taken Pfizer’s COVID antiviral drug, Paxlovid, and are experiencing rebounding symptoms after initially feeling better. NBC’s Linda Gaudino reports.
-
Is Paxlovid, the COVID Pill, Reaching Those Who Most Need It? The Government Won't Say
Paxlovid and molnupiravir are the go-to treatments for non-hospitalized patients, replacing nearly all the monoclonal antibody infusions, which are less effective against current COVID strains.
-
COVID Antiviral Pills: What to Know and How to Get Free Same-Day Delivery in NYC
New York City COVID infections have been on the rise once again in recent weeks, and while there’s no corresponding increase in severity, the health commissioner is reminding the public and providers that antiviral pills are effective treatments, too. Paxlovid, specifically, can reduce the risk of hospitalization and death by up to 88% when taken within five days of symptoms…
-
NYC Raises COVID Alert Level Amid Continued Rise in Cases
NYC is raising its COVID alert level as the number of new cases rises. It is a new alert system put into effect earlier in 2022, and for now it has been raised to medium, which won’t yet bring new restrictions, but that could change if it goes higher. NBC New York’s Andrew Siff reports.
-
Biden Admin to Promote Availability of COVID Antiviral Pill
President Joe Biden and his administration want Americans and their doctors to know that the country has an ample supply of the life-saving COVID-19 antiviral treatment Paxlovid and that it no longer needs to be rationed
-
NYC Wants to Remind Us Antiviral Pills Work Real Well Against Severe COVID, Too
NYC wants to make sure doctors across the city are reminding you about these alternative, highly effective COVID treatments. Some can even land on your doorstep via same-day delivery at no cost to you.
-
COVID BA.2 Subvariant: Why There Seem to Be More Cases in Heavily Vaccinated Areas
COVID numbers are once again creeping up across the region as the BA.2 subvariant spreads, but this time there’s a bit of a twist, as infections seem to be most prevalent in the most-vaccinated parts of the city. NBC New York’s Chris Glorioso reports on why that might be.
-
EXPLAINER: New, Easy-to-Use COVID-19 Pills Come With a Catch
Newly infected COVID-19 patients have two new treatment options that can be taken at home.
-
FDA Approves First COVID-19 Pill for Emergency Use
The Food and Drug Administration approved an emergency use authorization for the first oral antiviral treatment of COVID-19.
-
Pfizer: Our New COVID-19 Pill Cuts Severe Illness by 89%
Pfizer says the company stopped clinical trials for its new coronavirus antiviral treatment early because the data was overwhelmingly successful.